Skip to content

Adverse Events Among Hospitalized Patients in China

Adverse Events Among Hospitalized Patients: A Multicenter Evaluation of Four Detection Methods

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07705204
Enrollment
2807
Registered
2026-07-15
Start date
2025-08-28
Completion date
2026-10-01
Last updated
2026-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse Event

Keywords

Adverse event (AE), Harvard Medical Practice Study (HMPS), Global Trigger Tool (GTT), Patient Safety Indicator (PSI), Incident Reporting System (IRS), Patient Safety

Brief summary

The goal of this observational study is to learn about the incidence and characteristics of adverse events (AEs) among hospitalized patients in China and to compare 4 commonly used methods for detecting these events. The main questions it aims to answer are: How common are AEs among hospitalized patients, and what are their characteristics (types, severity, and preventability) in China? How do 4 commonly used methods, including the Harvard Medical Practice Study (HMPS), Global Trigger Tool (GTT), Patient Safety Indicators (PSIs), and incident reporting systems (IRSs), compare in detecting AEs? Researchers review randomly selected medical records from 5 hospitals in China to identify AEs, assess their type, severity, and preventability, and evaluate the performance of the 4 detection methods.

Interventions

OTHERNot applicable- observational study

This is a retrospective cross-sectional study based on medical record review. The study assesses AE incidence and characteristics and compares AE detection methods, with no intervention administered to participants.

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER
Beijing No.6 Hospital
CollaboratorUNKNOWN
Beijing Longfu Hospital
CollaboratorUNKNOWN
Beijing Puren Hospital
CollaboratorUNKNOWN
Beijing Hepingli Hospital
CollaboratorUNKNOWN

Study design

Observational model
CASE_CROSSOVER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age ≥18 years and a length of stay of at least 24 hours

Exclusion criteria

* Patients admitted primarily for psychiatric disorders, palliative care, or rehabilitation were excluded.

Design outcomes

Primary

MeasureTime frameDescription
Adverse event incidenceDuring the index admission, including review of relevant prior hospitalization records and all available records through 30 days after discharge.The proportion of admissions with at least one adverse event.

Secondary

MeasureTime frameDescription
Types of adverse eventDuring the index admission, including review of relevant prior hospitalization records and all available records through 30 days after discharge
Preventability of adverse eventDuring the index admission, including review of relevant prior hospitalization records and all available records through 30 days after dischargeAdverse event with 6-point Likert scale scores ≥4 were considered preventable.
Severity of adverse eventsDuring the index admission, including review of relevant prior hospitalization records and all available records through 30 days after dischargeSeverity was graded using the National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) classification.
Sensitivity of adverse event detection methodsAfter completion of AE screening, adjudication, and re-review of randomly sampled screen-negative admissionsAdmission-level sensitivity was calculated for the Harvard Medical Practice Study (HMPS), Global Trigger Tool (GTT), Patient Safety Indicators (PSIs), and incident reporting systems (IRSs).
Specificity of adverse event detection methodsAfter completion of AE screening, adjudication, and re-review of randomly sampled screen-negative admissionsAdmission-level specificity was calculated for the Harvard Medical Practice Study (HMPS), Global Trigger Tool (GTT), Patient Safety Indicators (PSIs), and incident reporting systems (IRSs).
Positive predictive value (PPV) of adverse event detection methodsAfter completion of AE screening, adjudication, and re-review of randomly sampled screen-negative admissionsAdmission-level positive predictive value (PPV) was calculated for the Harvard Medical Practice Study (HMPS), Global Trigger Tool (GTT), Patient Safety Indicators (PSIs), and incident reporting systems (IRSs).
Negative predictive value (NPV) of adverse event detection methodsAfter completion of AE screening, adjudication, and re-review of randomly sampled screen-negative admissionsAdmission-level negative predictive value (NPV) was calculated for the Harvard Medical Practice Study (HMPS), Global Trigger Tool (GTT), Patient Safety Indicators (PSIs), and incident reporting systems (IRSs).

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 16, 2026